
Insider Selling: Meyer Andrew Hollman, Janux Therapeutics Inc [JANX] Chief Business Officer divested 3,333 shares
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Janux Therapeutics Inc’s filing revealed that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Janux Therapeutics Inc’s filing revealed that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Janux Therapeutics Inc’s recently made public that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11
Janux Therapeutics Inc’s recent filing unveils that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.1
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or